ClinicalTrials.Veeva

Menu

Developmentally Supportive Care on Neurobehavioral Outcome of Preterm Very Low Birth Weight Neonates (DSC)

L

Lady Hardinge Medical College

Status

Unknown

Conditions

Very Low Birth Weight Baby

Treatments

Other: developmentally supportive care

Study type

Interventional

Funder types

Other

Identifiers

NCT02817022
Developmental supportive care

Details and patient eligibility

About

Enrolled neonates will be provided routine supportive care as per existing neonatal intensive care unit (NICU)protocols. This will be carried out in the initial 6 months (0-180 days) of study commencement. This group will serve as control group (group A). During subsequent 6 months (181-360 days) of the study period, enrolled neonates fulfilling the inclusion criteria will be provided routine supportive care and the components of developmentally supportive care (DSC).

Full description

Enrolled neonates will be provided routine supportive care as per existing NICU protocols. This will be carried out in the initial 6 months (0-180 days) of study commencement. This group will serve as control group (group A). During subsequent 6 months (181-360 days) of the study period, enrolled neonates fulfilling the inclusion criteria will be provided routine supportive care and the components of developmentally supportive care (DSC). DSC components will be strictly emphasized on protected sleep, pain and stress assessment and management, activities of daily living (positioning, feeding and skin care), the healing environment. This group will be designated as group B. Both the groups will receive appropriate management for their morbidities as per existing NICU protocols. Both the groups will be followed up till 37 weeks of gestation where in their neurobehavioral assessment will be performed using Neurobehavioural assessment of preterm infants score.

In both the groups all the baseline data regarding antenatal factors will be recorded in a predesigned proforma such as age, gravid, Gestational age, Chorioamnionitis, Prenatal steroids, Multiple pregnancy, maternal comorbidities (preeclampsia, gestational diabetes mellitus), mode of delivery etc.

Enrollment

120 estimated patients

Sex

All

Ages

1 day to 37 weeks old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • All stable preterm very low birth weight babies not on invasive mechanical ventilation
  • Hemodynamically stable
  • Parental consent

Exclusion criteria

  • Babies with major congenital anomalies
  • Asphyxia (Apgar score <3 at 5mins).
  • Acute bilirubin encephalopathy
  • Hypoglycemia at enrollment
  • Clinical Chorioamnionitis(fever > 100.4 ◦ f , uterine fundal tenderness, maternal tachycardia (>100/min), fetal tachycardia (>160/min) and purulent or foul amniotic fluid )
  • History of birth trauma

Trial design

Primary purpose

Supportive Care

Allocation

N/A

Interventional model

Single Group Assignment

Masking

None (Open label)

120 participants in 1 patient group

developmentally supportive care
Other group
Description:
enrolled neonates will be provided routine supportive care as per existing NICU protocols. This will be carried out in the initial 6 months (0-180 days) of study commencement. This group will serve as control group (group A). During subsequent 6 months (181-360 days) of the study period, enrolled neonates fulfilling the inclusion criteria will be provided routine supportive care and the components of developmentally supportive care(DSC). DSC components will be strictly emphasized on protected sleep, pain and stress assessment and management, activities of daily living (positioning, feeding and skin care), the healing environment. This group will be designated as group B
Treatment:
Other: developmentally supportive care

Trial contacts and locations

2

Loading...

Central trial contact

VIKRAM DATTA, MD,DNB; ARVIND SAILI, MD,FRCPCH

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems